Iterum Therapeutics plc (ITRM)
About Iterum Therapeutics plc
Iterum Therapeutics plc is an American company.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2021
- $0
- Net income
- -$24.8M
- Total assets
- $44.6M
Source: SEC EDGAR · updated Jun 8, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $18.7M
- Operating income
- -$18.7M
- Income tax
- $240.0K
- Net income
- -$24.8M
- EPS (basic)
- $-1.26
- EPS (diluted)
- $-1.26
Balance sheet
- Total assets
- $44.6M
- Current assets
- $24.8M
- Total liabilities
- $48.7M
- Current liabilities
- $17.6M
- Shareholders’ equity
- -$4.1M
Cash flow
- Operating cash flow
- -$26.8M
- Investing cash flow
- $18.2M
- Financing cash flow
- $26.7M
- Net cash flow
- $18.1M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- EPS (diluted)
- $-1.26
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Iterum Therapeutics plc (ITRM) Stock Price
- Reported a net loss of $24.8M in FY2021.
- Trading 97% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Iterum Therapeutics plc.
Write a review
News about Iterum Therapeutics plc
News & sentiment via Polygon.io
Iterum Therapeutics plc: frequently asked questions
Is Iterum Therapeutics plc an American company?
Iterum Therapeutics plc is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is Iterum Therapeutics plc publicly traded?
Yes — Iterum Therapeutics plc is a publicly traded company. Its stock trades under the ticker symbol ITRM on the NASDAQ.
What does Iterum Therapeutics plc do?
Iterum Therapeutics plc is an American Pharmaceuticals company in the Health & Beauty sector.